VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VVOS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VVOSVivos Therapeutics, Inc.
$0.48$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVVOSQuarterly Cash Flow

Vivos Therapeutics, Inc. (VVOS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Vivos Therapeutics, Inc. (VVOS) quarterly cash flow statement — complete operating, investing & financing history

VVOS Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations-6.01M-3.81M-4.16M-3.49M-3.8M-2.94M-4.19M-3.05M-2.52M-2.75M-2.8M-2.86M-3.54M-3M-5.84M-4.66M-6.08M-4.12M-4.06M-3.69M
Operating CF Margin %-116.9%-99.69%-61.34%-91.47%-125.86%-79.5%-108.47%-75.19%-73.59%-84.61%-84.82%-84.21%-91.76%-75.95%-137.59%-111.45%-166.9%-93.8%-89.27%-82.14%
Operating CF Growth %-58.32%-29.66%0.62%-14.63%-50.87%-6.99%-49.54%-6.61%28.91%8.4%52.07%38.69%41.81%27.22%-43.95%-26.24%-57.53%-13.92%-549.7%-269.22%
Net Income-7.75M-6.95M-5.4M-5.01M-3.86M-2.83M-2.62M-1.93M-3.76M-4.26M-2.09M-5.53M-1.7M-6.09M-5.43M-6.81M-5.51M-7.39M-5.45M-4.04M
Depreciation & Amortization454K442K384K306K177K144K146K145K146K149K149K148K175K169K176K283K41K168.23K192.5K194.77K
Stock-Based Compensation151K47K55K242K317K57K142K270K299K152K189K459K306K775K350K662K609K463.29K1.11M648.05K
Deferred Taxes000000000192K0-5.94M00000911.28K00
Other Non-Cash Items654K-100K0100K05K-2.62M26K0112K-1.76M6.99M-2.55M-124K244K405K-1.04M-7.48K-9.7K-5.87K
Working Capital Changes482K2.75M799K871K-426K-319K757K-1.56M802K906K713K1.01M233K2.27M-1.18M794K-174K1.74M99.79K-488.08K
Change in Receivables-188K553K-501K19K-288K24K-59K131K-324K26K99K-6K136K409K-74K210K201K2.63M-372.44K-1.8M
Change in Inventory0000000000-801K1.46M00000346.68K-12.71K-577.48K
Change in Payables318K-424K340K499K109K22K-953K-471K354K616K204K-170K84K767K-607K373K-42K220.17K901.45K426.67K
Cash from Investing-18K-1.58M83K-5.91M-122K-165K-192K-60K-151K-165K-154K-245K-289K-200K-100K-504K-120K-382.35K-431.97K-1.53M
Capital Expenditures-18K-893K893K-771K-122K-165K211K-60K-151K-165K-154K-245K-239K-200K-100K-504K-120K-382.65K-440.46K-1.31M
CapEx % of Revenue0.35%23.35%13.17%20.18%4.05%4.46%5.47%1.48%4.42%5.08%4.67%7.22%6.2%5.06%2.36%12.05%3.29%8.71%9.69%29.16%
Acquisitions0-50K5.13M-5.13M000000000000000-225K
Investments--------------------
Other Investing0-638K-5.95M000-403K00000-50K000-120K3018.49K-220.79K
Cash from Financing6.11M4.33M2.76M11.46M03.05M3.79M7.4M3.63M3.57M007.36M0000-434-1.17M25.37M
Debt Issued (Net)980K1.53M-531K9.64M0000000000000000
Equity Issued (Net)5.13M2.8M3.29M1.82M03.5M3.79M7.4M3.63M4M008M00000-1.17M0
Dividends Paid00000000000000000000
Share Repurchases000000000000000001.5M-1.5M0
Other Financing00000-446K000-432K00-645K0000-434-50025.37M
Net Change in Cash81K-1.06M-1.31M2.06M-3.92M-51K-592K4.29M968K655K-2.95M-3.1M3.53M-3.2M-5.94M-5.17M-6.2M-4.5M-5.66M20.14M
Free Cash Flow-6.01M-4.71M-3.27M-4.26M-3.92M-3.1M-3.98M-3.11M-2.67M-2.91M-2.95M-3.1M-3.78M-3.2M-5.94M-5.17M-6.2M-4.5M-4.5M-5M
FCF Margin %-116.9%-123.04%-48.18%-111.65%-129.91%-83.96%-103.01%-76.67%-78.01%-89.69%-89.49%-91.43%-97.95%-81.01%-139.94%-123.49%-170.2%-102.51%-98.96%-111.29%
FCF Growth %-53.39%-51.53%17.81%-37.23%-46.91%-6.59%-34.6%-0.13%29.41%8.97%50.29%39.93%39.08%28.96%-32.08%-3.24%-50.44%-21.3%-606.64%-396.41%
FCF per Share-0.41-0.51-0.30-0.47-0.46-0.53-0.60-0.96-1.16-1.59-2.47-2.59-3.81-3.48-7.00-6.08-7.30-4.89-5.40-6.03
FCF Conversion (FCF/Net Income)0.78x0.55x0.77x0.70x0.98x1.04x1.60x1.58x0.67x0.65x1.34x0.52x2.08x0.49x1.08x0.67x1.14x0.56x0.74x0.91x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000